1 mg estradiol/2 mg drospirenone (Angeliq®)
Following a full submission
1 mg estradiol / 2 mg drospirenone (Angeliq) is not recommended for use within NHS Scotland for prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or have contra-indications to, other medicinal products approved for the prevention of osteoporosis.
It maintains bone mineral density, relative to placebo, in post-menopausal women. However, no evidence of cost-effectiveness has been presented.
|Drug Name:||1 mg estradiol/2 mg drospirenone (Angeliq®)|
|SMC Drug ID:||227/05|
|Manufacturer:||Schering Health Care Ltd|
|Indication:||Prevention of osteoporosis|
|Sub Category:||6.4 Sex Hormones|
|Submission Type:||Full submission|
|Date Advice Published:||9 January 2006|